Form 4 for ENOV Enovis CORP
Accepted 2021-11-10 00:00:00 ET · period of report 2021-11-08 · accession 0001209191-21-063956 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-10 | 2021-11-08 | ENOV | PRYOR DANIEL A | EVP, Strategy, Business Dev | S - Sale+OE | $53.03 | -556 | 164.3K | -0.3% | -$29.5K |
| D | 2021-11-10 | 2021-11-08 | ENOV | PRYOR DANIEL A | EVP, Strategy, Business Dev | M - OptEx | $52.02 | +556 | 164.8K | +0.3% | +$28.9K |
| D | 2021-11-10 | 2021-11-08 | ENOV | PRYOR DANIEL A | EVP, Strategy, Business Dev | M - OptEx | $0.00 | -556 | 87.2K | -0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $.001 | 2021-11-08 | S | D | 556 | $53.03 | 164,257 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. (F2) The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.25, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. |
| 2 | Common | Common stock, par value $.001 | 2021-11-08 | M | A | 556 | $52.02 | 164,813 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2021-11-08 | M | D | 556 | $0.00 | 87,209 | D | $52.02 · — to 2022-02-15 | 556 Common stock, par value $.001 | (F3) The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 2/16/2015. |